106 related articles for article (PubMed ID: 7346064)
1. In vivo enhancement of the experimental oncostatic effect of RFCNU by its encapsulation in liposomes.
Mathé G; Bothorel P
Biomedicine; 1981 Dec; 35(7-8):201-2. PubMed ID: 7346064
[No Abstract] [Full Text] [Related]
2. Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.
Hayat M; Bourut C; Chenu E; Montero JL; Imbach JL; MacDonald JS; Mathé G
Cancer Chemother Pharmacol; 1979; 3(4):217-21. PubMed ID: 161207
[No Abstract] [Full Text] [Related]
3. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
Mayo JG
Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
[No Abstract] [Full Text] [Related]
4. [Effect of N-alkyl-N-nitrosourea on the protein-synthesizing system of liver and hepatoma 22a cells].
Abakumova OIu; Ugarova TIu; Pilipenko NN; Kutsenko NG; Lerman MI
Biull Eksp Biol Med; 1973 Oct; 75(10):51-4. PubMed ID: 4360614
[No Abstract] [Full Text] [Related]
5. Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.
Maral R; Bourut C; Chenu E; Mathe G; Bernon R; Lussan C; Imbach JL; Schein P; Bothorel P
Oncology; 1985; 42(2):122-8. PubMed ID: 3157909
[TBL] [Abstract][Full Text] [Related]
6. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.
Imbach JL; Montero JL; Moruzzi A; Serrou B; Chenu E; Hayat M; Mathe G
Biomedicine; 1975 Dec; 23(10):410-3. PubMed ID: 1222217
[TBL] [Abstract][Full Text] [Related]
7. Further studies on chemotherapy of experimental brain tumors.
Shapiro WR
Neurology; 1970 Apr; 20(4):390-1. PubMed ID: 5535017
[No Abstract] [Full Text] [Related]
8. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
Shapiro WR
Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762
[No Abstract] [Full Text] [Related]
9. [Liposome encapsulation as a possibility for the improvement of tumor chemotherapy].
Fichtner I; Reszka R; Elbe B; Arndt D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):658-63. PubMed ID: 6172330
[No Abstract] [Full Text] [Related]
10. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs.
Geran RI; Congleton GF; Dudeck LE; Abbott BJ; Gargus JL
Cancer Chemother Rep 2; 1974 Dec; 4(4):53-87. PubMed ID: 4447935
[No Abstract] [Full Text] [Related]
11. Preliminary study of the effects of vitamin A on antineoplastic activities of chemotherapeutic agents in glioma.
Tani E; Morimura T; Kaba K; Itagaki T
Neurol Med Chir (Tokyo); 1980 Jul; 20(7):665-77. PubMed ID: 6160411
[No Abstract] [Full Text] [Related]
12. The use of dihydrofolate reductase as a signal for scheduling optimal treatment with antileukemic agents.
Hardesty CT; Chen D; Mead JA
Cancer Res; 1972 Mar; 32(3):458-61. PubMed ID: 5061301
[No Abstract] [Full Text] [Related]
13. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
Drummond DC; Meyer O; Hong K; Kirpotin DB; Papahadjopoulos D
Pharmacol Rev; 1999 Dec; 51(4):691-743. PubMed ID: 10581328
[No Abstract] [Full Text] [Related]
14. Studies of the mechanism of action of the tumour-inhibitory nitrosoureas.
Connors TA; Hare JR
Biochem Pharmacol; 1975 Dec; 24(23):2133-40. PubMed ID: 1212261
[No Abstract] [Full Text] [Related]
15. Liposomes as drug carriers in cancer therapy: hyperthermia and pH sensitivity as modalities for targeting.
Yatvin MB; Cree TC; Tegmo-Larsson IM; Gipp JJ
Strahlentherapie; 1984 Dec; 160(12):732-40. PubMed ID: 6393456
[No Abstract] [Full Text] [Related]
16. [Antineoplastic nitrosoureas].
Tang WC
Yao Xue Xue Bao; 1982 Jun; 17(6):472-9. PubMed ID: 7148473
[No Abstract] [Full Text] [Related]
17. [Alkyl nitrosoureidodioxans and alkyl nitrosoureidopropane diols -- new groups of antitumor compounds].
Kon'kov SA; Stukov AN; Reztsova VV; Krylova IM; Ivin BA; VA Filov
Vopr Onkol; 1998; 44(1):97-9. PubMed ID: 9578740
[TBL] [Abstract][Full Text] [Related]
18. [Experimental affinity chemotherapy in cancer].
Chen GJ; Wang SZ
Sheng Li Ke Xue Jin Zhan; 1986 Apr; 17(2):154-9. PubMed ID: 2431479
[No Abstract] [Full Text] [Related]
19. Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU.
Mathe G; Schein P; MacDonald JS; Imbach JL; Misset JL; De Vassal F; Ribaud P; Serrou B; Gouveia J; Musset M; Machover D; Schwarzenberg L; Jasmin C; de Jager R
Eur J Cancer Clin Oncol; 1982 Aug; 18(8):727-32. PubMed ID: 6891323
[No Abstract] [Full Text] [Related]
20. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (VI)].
Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M
Eisei Shikenjo Hokoku; 1982; (100):163-5. PubMed ID: 7183380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
